chalcone has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csala, M; Csámpai, A; Duró, C; Gurbi, B; Móra, I; Murányi, J; Németh, K; Simon, J; Varga, A | 1 |
| Celentano, A; Cirillo, N; Farah, CS; McCullough, M; Paolini, R; Yap, T; Yiannis, C; Zhang, P | 1 |
2 other study(ies) available for chalcone and Squamous Cell Carcinoma of Head and Neck
| Article | Year |
|---|---|
Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Cell Death; Cell Line, Tumor; Chalcone; Chalcones; Erlotinib Hydrochloride; Head and Neck Neoplasms; Humans; Necrosis; Squamous Cell Carcinoma of Head and Neck; Triazoles | 2023 |
Kava constituents exert selective anticancer effects in oral squamous cell carcinoma cells in vitro.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Flavonoids; Gas Chromatography-Mass Spectrometry; Humans; Kava; Keratinocytes; Mouth Neoplasms; Plant Extracts; Pyrans; Pyrones; Squamous Cell Carcinoma of Head and Neck | 2020 |